Last updated on September 2018

OPsumit USers Registry

Brief description of study

Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) and to describe clinical characteristics and outcomes of patients newly treated with Opsumit in the post-marketing setting.

Clinical Study Identifier: NCT02126943

Contact Investigators or Research Sites near you

Start Over

CTD Clinical Trials Disclosure Desk

Investigator Site
Zephyrhills, FL United States
  Connect »